Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002400203 | SCV001188376 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-07-03 | criteria provided, single submitter | clinical testing | The c.7125A>G variant (also known as p.K2375K), located in coding exon 47, results from an A to G substitution at nucleotide position 7125 of the NF1 gene. This nucleotide substitution does not change the amino acid at codon 2375. This nucleotide position is well conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by ESEfinder to weaken the efficiency of the native splice donor site, but is not predicted to have a deleterious effect on this splice donor site by BDGP; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |